Cargando…

Elimination of lymphatic filariasis: current perspectives on mass drug administration

Following the London declaration on neglected tropical diseases (NTDs) in 2012 and inspired by the WHO 2020 roadmap to control or eliminate NTDs, the Global Programme to Eliminate Lymphatic Filariasis (GPELF) intensified preventive chemotherapy and management of morbidity as the two main strategies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gyapong, John O, Owusu, Irene O, da-Costa Vroom, Frances B, Mensah, Ernest O, Gyapong, Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047620/ https://www.ncbi.nlm.nih.gov/pubmed/30050352 http://dx.doi.org/10.2147/RRTM.S125204

Ejemplares similares

Data reporting constraints for the lymphatic filariasis mass drug administration activities in two districts in Ghana: A qualitative study
por: da-Costa Vroom, Frances Baaba, et al.
Publicado: (2015)

National Mass Drug Administration Costs for Lymphatic Filariasis Elimination
por: Goldman, Ann S., et al.
Publicado: (2007)

Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis
por: Krentel, Alison, et al.
Publicado: (2020)

Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana
por: Biritwum, Nana-Kwadwo, et al.
Publicado: (2017)

African regional progress and status of the programme to eliminate lymphatic filariasis: 2000–2020
por: Deribe, Kebede, et al.
Publicado: (2020)

Fifteen years of programme implementation for the elimination of Lymphatic Filariasis in Ghana: Impact of MDA on immunoparasitological indicators
por: Biritwum, Nana-Kwadwo, et al.
Publicado: (2017)

How lymphatic filariasis was eliminated from an urban poor setting in Santo Domingo, Dominican Republic
por: Gonzales, Manuel, et al.
Publicado: (2019)

Impact of mass drug administration for elimination of lymphatic filariasis in Nepal
por: Ojha, Chet Raj, et al.
Publicado: (2017)

Factors determining noncompliance to mass drug administration for lymphatic filariasis elimination
por: Nujum, Zinia T, et al.
Publicado: (2012)

Evaluating the availability and quality of services for lymphatic filariasis morbidity in Ghana
por: Edmiston, Melissa, et al.
Publicado: (2023)

Elimination of Lymphatic Filariasis in The Gambia
por: Rebollo, Maria P., et al.
Publicado: (2015)

Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis
por: Stolk, Wilma A., et al.
Publicado: (2013)

WILL MASS DRUG ADMINISTRATION ELIMINATE LYMPHATIC FILARIASIS? EVIDENCE FROM NORTHERN COASTAL TANZANIA
por: PARKER, MELISSA, et al.
Publicado: (2013)

Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination
por: Alexander, Neal D. E.
Publicado: (2015)

Epidemiological and Entomological Evaluations after Six Years or More of Mass Drug Administration for Lymphatic Filariasis Elimination in Nigeria
por: Richards, Frank O., et al.
Publicado: (2011)

Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study
por: Khaemba, Christabel, et al.
Publicado: (2021)

Global Elimination of Lymphatic Filariasis: A “Mass Uprising of Compassion”
por: Addiss, David G.
Publicado: (2013)

A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
por: Krentel, Alison, et al.
Publicado: (2013)

The Role of Personal Opinions and Experiences in Compliance with Mass Drug Administration for Lymphatic Filariasis Elimination in Kenya
por: Njomo, Doris W., et al.
Publicado: (2012)

Elimination of Lymphatic Filariasis: Mass Drug Administration in Endemic Areas of (Bidar District) Karnataka-2008
por: Ranganath, TS, et al.
Publicado: (2012)

Mass Drug Administration for the Elimination of Lymphatic Filariasis — Port-au-Prince, Haiti, 2011–2012
por: Streit, Thomas, et al.
Publicado: (2013)

Improved assessment of mass drug administration and health district management performance to eliminate lymphatic filariasis
por: Maroto-Camino, Carmen, et al.
Publicado: (2019)

Assessing factors influencing communities’ acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana
por: Niles, Reza A., et al.
Publicado: (2021)

Reduction in Acute Filariasis Morbidity during a Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea
por: Tisch, Daniel J., et al.
Publicado: (2011)

Two decades of public health achievements in lymphatic filariasis (2000–2020): reflections, progress and future challenges
por: Malecela, Mwelecele, et al.
Publicado: (2020)

The history of the elimination of lymphatic filariasis in China
por: De-jian, Sun, et al.
Publicado: (2013)

Evaluating the Evidence for Lymphatic Filariasis Elimination
por: Davis, Emma L., et al.
Publicado: (2019)

Pacific collaboration to eliminate lymphatic filariasis
por: Ichimori, Kazuyo, et al.
Publicado: (2005)

Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities
por: Biritwum, Nana Kwadwo, et al.
Publicado: (2019)

Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines
por: Amarillo, Maria Lourdes E, et al.
Publicado: (2008)

An Evaluation of Coverage and Compliance of Mass Drug Administration 2006 for Elimination of Lymphatic Filariasis in Endemic Areas of Gujarat
por: Kumar, Pradeep, et al.
Publicado: (2008)

A mixed-methods exploration into the resilience of community drug distributors conducting mass drug administration for preventive chemotherapy of lymphatic filariasis and onchocerciasis in Côte d’Ivoire and Uganda
por: Dilliott, Daniel, et al.
Publicado: (2022)

Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006
por: Allen, Tammy, et al.
Publicado: (2017)

Progress towards elimination of lymphatic filariasis in the Americas region
por: Fontes, Gilberto, et al.
Publicado: (2020)

Progress on elimination of lymphatic filariasis in Sierra Leone
por: Koroma, Joseph B., et al.
Publicado: (2018)

Elimination of lymphatic filariasis in South East Asia
por: Specht, Sabine, et al.
Publicado: (2019)

Lymphatic filariasis in Brazil: epidemiological situation and outlook for elimination
por: Fontes, Gilberto, et al.
Publicado: (2012)

Mass drug administration for elimination of lymphatic filariasis: Recent experiences from a district of West Bengal, India
por: Ghosh, Santanu, et al.
Publicado: (2013)

Coverage and Awareness of and Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis in Burdwan District, West Bengal, India
por: Roy, Rabindra Nath, et al.
Publicado: (2013)

Coverage of mass drug administration (MDA) and operational issues in elimination of lymphatic filariasis in selected districts of Jharkhand, India
por: Kumar, Dhananjay, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9gf86637a8v1k1fo0a3oeupnud